Collaborative Cohort of Cohorts for COVID-19 Research (C4R): Severe Asthma Research Program (SARP)

Cohort Description The Severe Asthma Research Program (SARP) has been investigating the clinical, physiologic and molecular phenotypes of asthma since 2000. It is currently following ~400 deeply phenotyped asthma patients. Data Being Submitted Wave 3 questionnaire data includes 80 variables for up to 242 SARP participants in C4R.Dried Blood Spot/Serosurvey data includes 19 variables for up to 224 SARP participants in C4R.Derived data includes 61 variables for up to 480 SARP participants in C4R.Phenotype data includes 86 variables for up to 480 SARP participants in C4R.Health Care Utilization data includes 20 variables for up to 14 SARP participants in C4R.Lung CT data includes 58 variables for up to 161 SARP participants in C4R.]]>
Please see phs002788.]]>
Please see phs002788.This new version includes C4R Freeze 2.0 data, which incorporates newly collected data from Wave 3; a review of medical records for COVID-19 events; Serosurvey 2.0; newly harmonized datasets for lung CT, brain MRI, and neurocognitive assessments; and updated datasets for derived and phenotype variables. Please note that Serosurvey 2.0, lung CT, brain MRI, and neurocognitive assessments are not available for all cohorts.]]>